Combination chemotherapy in disseminated carcinoma of the breast.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008727:Methotrexate / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced; D009362:Neoplasm Metastasis; D011014:Pneumonia / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced; D014750:Vincristine / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D014750:Vincristine; D003520:Cyclophosphamide; D005472:Fluorouracil; D011241:Prednisone; D008727:Methotrexate